Dimensional Fund Advisors LP boosted its stake in shares of Teladoc Health Inc (NYSE:TDOC) by 95.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 207,443 shares of the health services provider’s stock after buying an additional 101,498 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Teladoc Health were worth $10,282,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of TDOC. Advisory Services Network LLC lifted its stake in shares of Teladoc Health by 13.2% during the fourth quarter. Advisory Services Network LLC now owns 22,155 shares of the health services provider’s stock valued at $1,098,000 after buying an additional 2,585 shares during the period. Amalgamated Bank lifted its stake in shares of Teladoc Health by 150.2% during the fourth quarter. Amalgamated Bank now owns 9,843 shares of the health services provider’s stock valued at $488,000 after buying an additional 5,909 shares during the period. Macquarie Group Ltd. lifted its stake in shares of Teladoc Health by 101.5% during the fourth quarter. Macquarie Group Ltd. now owns 1,125,275 shares of the health services provider’s stock valued at $55,780,000 after buying an additional 566,839 shares during the period. Harbor Advisors LLC purchased a new position in shares of Teladoc Health during the fourth quarter valued at approximately $248,000. Finally, Legal & General Group Plc lifted its stake in shares of Teladoc Health by 6.2% during the fourth quarter. Legal & General Group Plc now owns 26,209 shares of the health services provider’s stock valued at $1,299,000 after buying an additional 1,540 shares during the period.

In other news, SVP Andrew Turitz sold 31,960 shares of the stock in a transaction on Thursday, April 4th. The shares were sold at an average price of $55.82, for a total value of $1,784,007.20. Following the completion of the sale, the senior vice president now owns 13,455 shares of the company’s stock, valued at $751,058.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jason N. Gorevic sold 30,000 shares of the stock in a transaction on Tuesday, March 19th. The stock was sold at an average price of $63.16, for a total transaction of $1,894,800.00. Following the completion of the sale, the chief executive officer now directly owns 653,851 shares of the company’s stock, valued at approximately $41,297,229.16. The disclosure for this sale can be found here. Insiders sold 156,351 shares of company stock valued at $9,088,666 in the last three months. Company insiders own 3.14% of the company’s stock.

TDOC has been the topic of a number of recent analyst reports. Zacks Investment Research raised shares of Teladoc Health from a “sell” rating to a “hold” rating in a research note on Monday, February 18th. TheStreet raised shares of Teladoc Health from a “d+” rating to a “c” rating in a research note on Wednesday, February 20th. Cantor Fitzgerald reaffirmed a “hold” rating and set a $70.00 price target (down previously from $83.00) on shares of Teladoc Health in a research note on Wednesday, February 27th. SunTrust Banks increased their price target on shares of Teladoc Health to $75.00 and gave the stock a “positive” rating in a research note on Monday, March 4th. Finally, Stephens initiated coverage on shares of Teladoc Health in a research note on Tuesday, April 16th. They set an “overweight” rating and a $75.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $83.67.

Teladoc Health stock opened at $58.07 on Wednesday. Teladoc Health Inc has a 52-week low of $42.08 and a 52-week high of $89.05. The firm has a market capitalization of $4.19 billion, a PE ratio of -40.33 and a beta of 1.25. The company has a quick ratio of 7.54, a current ratio of 7.54 and a debt-to-equity ratio of 0.42.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Tuesday, April 30th. The health services provider reported ($0.43) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.44) by $0.01. Teladoc Health had a negative net margin of 22.63% and a negative return on equity of 10.86%. The company had revenue of $128.57 million during the quarter, compared to analyst estimates of $127.99 million. During the same quarter in the prior year, the business earned ($0.39) earnings per share. The business’s quarterly revenue was up 43.4% compared to the same quarter last year. Research analysts anticipate that Teladoc Health Inc will post -1.53 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Teladoc Health Inc (NYSE:TDOC) Holdings Lifted by Dimensional Fund Advisors LP” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark laws. The original version of this story can be accessed at https://www.watchlistnews.com/teladoc-health-inc-nysetdoc-holdings-lifted-by-dimensional-fund-advisors-lp/3038983.html.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Further Reading: Hedge Funds Explained

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.